Cargando…
Corrigendum: Scorpion Venom Analgesic Peptide, BmK AGAP Inhibits Stemness and Epithelial-Mesenchymal Transition by Down-Regulating PTX3 in Breast Cancer
Autores principales: | Kampo, Sylvanus, Ahmmed, Bulbul, Zhou, Tingting, Owusu, Lawrence, Anabah, Thomas Winsum, Doudou, Natacha Raissa, Kuugbee, Eugene Dogkotenge, Cui, Yong, Lu, Zhili, Yan, Qiu, Wen, Qing-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276674/ https://www.ncbi.nlm.nih.gov/pubmed/34268108 http://dx.doi.org/10.3389/fonc.2021.639813 |
Ejemplares similares
-
Scorpion Venom Analgesic Peptide, BmK AGAP Inhibits Stemness, and Epithelial-Mesenchymal Transition by Down-Regulating PTX3 in Breast Cancer
por: Kampo, Sylvanus, et al.
Publicado: (2019) -
Monitoring the Early Antiproliferative Effect of the Analgesic–Antitumor Peptide, BmK AGAP on Breast Cancer Using Intravoxel Incoherent Motion With a Reduced Distribution of Four b-Values
por: Doudou, Natacha Raissa, et al.
Publicado: (2019) -
Scorpion Venom peptide, AGAP inhibits TRPV1 and potentiates the analgesic effect of lidocaine
por: Kampo, Sylvanus, et al.
Publicado: (2021) -
Inhibition of spinal MAPKs by scorpion venom peptide BmK AGAP produces a sensory-specific analgesic effect
por: Ruan, Jia-Ping, et al.
Publicado: (2018) -
BmK-YA, an Enkephalin-Like Peptide in Scorpion Venom
por: Zhang, Yan, et al.
Publicado: (2012)